News and Reports
-
Anthera's varespladib meets primary endpoint in phase 2 FRANCIS trial for the treatment of acute coronary syndrome
6 May 2009Download -
Ophthotech's positive results for their Novel Therapy for Wet AMD
4 May 2009Download -
Lux reports first oral drug for uveitis which reduces both inflammation and recurrence rate in potientially blinding eye disease
4 May 2009Download -
Mpex's new CBO Mark Wiggins joins from Biogen Idec
20 April 2009Download -
Lux Biosciences reports positive results from LUMINATE Phase 3 program of LX211 (LUVENIQ) in Uveitis
26 March 2009Download -
ESBATech ESBA105 demonstrates efficacy in the back of the eye to inhabit neovascularization
24 March 2009Download -
Anthera's IMPACTS trial demonstrates favorable interim results in preventing sickle cell complication
24 March 2009Download -
Nereus Pharmaceuticals initiates randomized phase 2 clinical trial in non-small cell lung cancer
23 March 2009Download -
MiCardia announces worlds' first dynamic heart valve repair on a beating heart
17 February 2009Download -
Newron announces improved motor function in phase III Parkinson's trial of Safinamade
3 February 2009Download -
Biomarin's Kuvan receives marketing approval in the EU
9 December 2008Download -
Broncus Technologies Secures 38$ Million in fundind round led by Ares Life Sciences
4 December 2008Download -
Sale of private portfolio company Panomics
12 November 2008Download -
Biovitrum extends ReFacto supply agreement with Wyeth until Dec. 31, 2015
12 November 2008Download -
Brahms announces new blood test better predicts heart failure outcomes in emergency setting
11 November 2008Download -
Paratek reports positive phase 2 clinical data on antibiotic PTK 0796
26 October 2008Download -
Mpex Pharmaceuticals presents new data on MP-376 in Cystic Fibrosis
23 October 2008Download -
Probiodrug's new Alzheimer's treatment paradigm published in Nature Medicine
28 September 2008Download -
Takeover of public portfolio company CryoCath Technologies
26 September 2008Download -
Biovitrum to acquire Kepivance, Stemgen and exclusively license
15 September 2008Download -
Basilea's Toctino (alitretinoin) receives first national marketing authorization in the UK
8 September 2008Download -
BRAHMS AG: Substantial success in the improvement of diagnosis of patients suffering from shortness of breath
1 September 2008Download -
Anthera Pharmaceuticals initiates FRANCIS in patients with acute coronary syndrome
25 August 2008Download -
Pelikan Technologies and Lilly form alliance to promote diabetes education
16 August 2008Download -
Anthera Pharmaceuticals completes $19 million financing
13 August 2008Download